These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 28647164)
1. Liver transplantation in New Orleans: parity in a world of disparity? Smith AA; Darden M; Al-Qurayshi Z; Paramesh AS; Killackey M; Kandil E; Parker G; Balart L; Friedlander P; Buell JF HPB (Oxford); 2017 Sep; 19(9):793-798. PubMed ID: 28647164 [TBL] [Abstract][Full Text] [Related]
2. Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist Candidates. Mustian MN; Shelton BA; MacLennan PA; Reed RD; White JA; Eckhoff DE; Locke JE; Allman RM; Gray SH Transplantation; 2019 Jul; 103(7):1425-1432. PubMed ID: 30418427 [TBL] [Abstract][Full Text] [Related]
3. Variation in access to the liver transplant waiting list in the United States. Mathur AK; Ashby VB; Fuller DS; Zhang M; Merion RM; Leichtman A; Kalbfleisch J Transplantation; 2014 Jul; 98(1):94-9. PubMed ID: 24646768 [TBL] [Abstract][Full Text] [Related]
4. Racial and ethnic disparities in access to liver transplantation. Mathur AK; Schaubel DE; Gong Q; Guidinger MK; Merion RM Liver Transpl; 2010 Sep; 16(9):1033-40. PubMed ID: 20818740 [TBL] [Abstract][Full Text] [Related]
5. Outcomes after liver transplantation of patients with Indo-Asian ethnicity. Rocha C; Perera MT; Roberts K; Bonney G; Gunson B; Nightingale P; Bramhall SR; Isaac J; Muiesan P; Mirza DF Transplantation; 2015 Apr; 99(4):860-6. PubMed ID: 25211517 [TBL] [Abstract][Full Text] [Related]
6. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA. Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564 [TBL] [Abstract][Full Text] [Related]
8. Disparities in liver transplantation before and after introduction of the MELD score. Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease. Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365 [TBL] [Abstract][Full Text] [Related]
10. Following the organ supply: assessing the benefit of inter-DSA travel in liver transplantation. Dzebisashvili N; Massie AB; Lentine KL; Schnitzler MA; Segev D; Tuttle-Newhall J; Gentry S; Freeman R; Axelrod DA Transplantation; 2013 Jan; 95(2):361-71. PubMed ID: 23250334 [TBL] [Abstract][Full Text] [Related]
11. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States. Rosenblatt R; Wahid N; Halazun KJ; Kaplan A; Jesudian A; Lucero C; Lee J; Dove L; Fox A; Verna E; Samstein B; Fortune BE; Brown RS Hepatology; 2021 Sep; 74(3):1523-1532. PubMed ID: 33779992 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630 [TBL] [Abstract][Full Text] [Related]
13. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Taber DJ; Gebregziabher M; Payne EH; Srinivas T; Baliga PK; Egede LE Transplantation; 2017 Feb; 101(2):402-410. PubMed ID: 26901080 [TBL] [Abstract][Full Text] [Related]
14. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185 [TBL] [Abstract][Full Text] [Related]
15. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Kwong AJ; Lai JC; Dodge JL; Roberts JP Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624 [TBL] [Abstract][Full Text] [Related]
16. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation. Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408 [TBL] [Abstract][Full Text] [Related]
17. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284 [TBL] [Abstract][Full Text] [Related]
18. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma. Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099 [TBL] [Abstract][Full Text] [Related]
19. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy. Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638 [TBL] [Abstract][Full Text] [Related]